Pharma Services Report: Q1 2026 
An in-depth look at the Q1 2026 Pharma Services sector, where Mirus' partners apply their…
PattiJune 27, 2026
Tools & Diagnostics Report: Q1 2026
An in-depth look at the Q1 2026 Tools & Diagnostics sector, where Mirus' partners apply…
PattiJune 26, 2026
Medical Devices Report: Q1 2026
An in-depth look at the Q1 2026 Medical Device sector, where Mirus' partners apply their…
PattiJune 16, 2026
Tools & Diagnostics Report: Q4 2025
An in-depth look at the Q4 2025 Tools & Diagnostics sector, where Mirus' partners apply…
PattiMarch 21, 2026
Pharma Services Report: Q4 2025
An in-depth look at the Q4 2025 Pharma Services sector, where Mirus' partners apply their…
PattiMarch 18, 2026
Medical Devices Report: Q4 2025
An in-depth look at the Q4 2025 Medical Device sector, where Mirus' partners apply their…
PattiFebruary 25, 2026
Pharma Services Report: Q3 2025 
An in-depth look at the Q3 2025 Pharma Services sector, where Mirus' partners apply their…
paganoDecember 7, 2025
Tools & Diagnostics Report: Q3 2025
An in-depth look at the Q3 2025 Tools & Diagnostics sector, where Mirus' partners apply…
PattiOctober 30, 2025
Medical Devices Report: Q3 2025
An in-depth look at the Q3 2025 Medical Device sector, where Mirus' partners apply their…
paganoOctober 13, 2025
Mirus Capital Advisors Expands Life Sciences & Healthcare Investment Banking Team with Strategic Additions of Thomas Busby and Nick Frame, PhD
Mirus Capital Advisors, a leading independent middle-market investment banking firm, is pleased to announce the…
paganoSeptember 16, 2025
About Mirus